Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 16Unknown 7Recruiting 7Terminated 4Withdrawn 3Active not recruiting 3Suspended 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 43Thoracic 30Other hematologic neoplasm 23Sarcoma 9CNS 9Plasma cell 6Myeloid 5Other solid neoplasm 3Genitourinary 3Gastrointestinal 2Dermatologic 2Classical hematology 2Other neoplasm 1Endocrine 1

Conditions

Retinoblastoma 3Retinal Neoplasms 1

Interventions

pembrolizumab 27Nivolumab 11Pemetrexed 10Cyclophosphamide 10Carboplatin 10atezolizumab 9Specimen Handling 8Cisplatin 8Ipilimumab 6Biopsy 6Injections 5tislelizumab 4spartalizumab 4fludarabine 4Vincristine 4Radiotherapy 4Proton Therapy 4Platinum 4Paclitaxel 4Drug Therapy 4Docetaxel 4Bevacizumab 41,2-diaminocyclohexaneplatinum II citrate 4durvalumab 3Trastuzumab 3Etoposide 3Cetuximab 3zimberelimab 2trametinib 2tocilizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Etoposide × Other solid neoplasm × Clear all
NCT02870907 2026-01-07

RB SFCE 09

Institut Curie

Phase 2 Active not recruiting
195 enrolled
Other solid neoplasm

Retinoblastoma

NCT02866136 2025-11-24

RETINO2011

Institut Curie

Phase 2 Active not recruiting
133 enrolled
Other solid neoplasm

Retinoblastoma, Retinal Neoplasms

NCT01783535 2024-04-16

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
174 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡